BI Asset Management Fondsmaeglerselskab A S Buys 261,967 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

BI Asset Management Fondsmaeglerselskab A S increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1,628.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 278,052 shares of the medical device company's stock after buying an additional 261,967 shares during the period. BI Asset Management Fondsmaeglerselskab A S owned 0.14% of Cooper Companies worth $25,561,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in COO. Byrne Asset Management LLC acquired a new position in Cooper Companies during the fourth quarter valued at approximately $33,000. OFI Invest Asset Management acquired a new position in shares of Cooper Companies during the 4th quarter worth $34,000. New Age Alpha Advisors LLC bought a new stake in shares of Cooper Companies during the 4th quarter worth $38,000. Covestor Ltd lifted its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares during the last quarter. Finally, West Financial Advisors LLC acquired a new stake in Cooper Companies in the fourth quarter valued at about $49,000. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently commented on COO shares. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. JPMorgan Chase & Co. cut their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Robert W. Baird cut their price objective on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Finally, Citigroup lowered their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Trading Up 1.8 %

Shares of Cooper Companies stock traded up $1.49 during midday trading on Thursday, reaching $82.33. The company had a trading volume of 377,028 shares, compared to its average volume of 1,417,888. The stock has a fifty day moving average price of $82.37 and a 200 day moving average price of $93.11. The Cooper Companies, Inc. has a fifty-two week low of $69.81 and a fifty-two week high of $112.38. The firm has a market cap of $16.46 billion, a PE ratio of 42.24, a P/E/G ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.